Publications Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel Disease Citation Rocio Sedano, Christopher Ma, Vipul Jairath, Brian G Feagan. Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 Jan;18(1):14-27. PMID: 35505771 PMCID: PMC9053496 Abstract In recent years, knowledge about the pathophysiology of inflammatory bowel disease (IBD) has led to the development of novel therapies and biologics with differing mechanisms of action. A major innovation has been the development of small molecules. Tags Clinical Trials, IBD, Inflammatory Bowel Disease, Ulcerative Colitis Read More
